HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roelof J C Kluin Selected Research

DNA (Deoxyribonucleic Acid)

1/2024Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
12/2021Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial.
10/2018XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data.
10/2015BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roelof J C Kluin Research Topics

Disease

16Neoplasms (Cancer)
05/2024 - 07/2013
3Triple Negative Breast Neoplasms
01/2024 - 01/2019
3Breast Neoplasms (Breast Cancer)
12/2021 - 01/2018
2Melanoma (Melanoma, Malignant)
05/2024 - 10/2021
2Inflammation (Inflammations)
03/2024 - 01/2019
1Carcinogenesis
03/2024
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
12/2021
1Carcinoma (Carcinomatosis)
01/2018
1Virus Diseases (Viral Diseases)
11/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2013
1Adenocarcinoma of Lung
07/2013
1Lung Neoplasms (Lung Cancer)
07/2013
1Stomach Neoplasms (Stomach Cancer)
03/2013

Drug/Important Bio-Agent (IBA)

4DNA (Deoxyribonucleic Acid)IBA
01/2024 - 10/2015
3RNA (Ribonucleic Acid)IBA
10/2021 - 07/2013
3Phosphotransferases (Kinase)IBA
01/2018 - 07/2013
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2024 - 03/2024
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 11/2013
1VorinostatFDA Link
05/2024
1Histone Deacetylase InhibitorsIBA
05/2024
1Mitogen-Activated Protein KinasesIBA
03/2024
1PlasticsIBA
03/2024
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2024
1Biomarkers (Surrogate Marker)IBA
01/2024
1Formaldehyde (Formol)FDA Link
01/2024
1InterferonsIBA
01/2024
1ParaffinIBA
01/2024
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024
1CytokinesIBA
01/2024
1Androgen Receptors (Androgen Receptor)IBA
01/2022
1enzalutamideIBA
01/2022
1AndrogensIBA
01/2022
1Capecitabine (Xeloda)FDA Link
01/2022
1Immune Checkpoint InhibitorsIBA
10/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020
1Estrogen ReceptorsIBA
01/2020
1EndonucleasesIBA
01/2020
1TamoxifenFDA LinkGeneric
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1Programmed Cell Death 1 ReceptorIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1PlatinumIBA
01/2018
1tyrosine receptor (receptor, tyrosine)IBA
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1AntigensIBA
11/2013
1Neoplasm Antigens (Tumor Antigens)IBA
11/2013
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
07/2013
1Cadherins (E-Cadherin)IBA
03/2013
1CateninsIBA
03/2013

Therapy/Procedure

5Therapeutics
01/2022 - 07/2013
3Drug Therapy (Chemotherapy)
01/2024 - 01/2018
1Transplantation
10/2021